Related Experiment Video

Updated: May 25, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Periventricular closure of a perimembranous VSD: treatment option in selected patients

Christian Schreiber1, Manfred Vogt, Andreas Kühn

  • 1Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University, Munich, Germany. schreiber@dhm.mhn.de

The Thoracic and Cardiovascular Surgeon
|January 27, 2012
PubMed

Insights

This study presents a novel periventricular closure technique for perimembranous ventricular septal defects (VSDs) in children. This minimally invasive approach avoids cardiopulmonary bypass, leading to a better cosmetic outcome and faster recovery.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Medical Devices

Background:

  • Ventricular septal defects (VSDs) are common congenital heart abnormalities.
  • Surgical repair using cardiopulmonary bypass (CPB) is the standard treatment.
  • Percutaneous VSD closure techniques face challenges with catheter size and patient weight.

Observation:

  • A 7-year-old female patient with a perimembranous VSD underwent periventricular closure.
  • The procedure was performed on a beating heart.
  • Echocardiography guided the implantation via a minimally invasive sternotomy.

Findings:

  • The periventricular closure was successfully and uneventfully performed.
  • This technique effectively closes the VSD without requiring CPB.
  • The minimally invasive approach offers cosmetic benefits.

Implications:

  • This method provides a favorable alternative to traditional CPB surgery for VSD repair.
  • The technique may lead to improved patient recovery times.
  • It expands minimally invasive options for treating congenital heart defects in pediatric patients.

More Related Videos

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...